Article
Unique features in the structure of the complex between HIV-1 reverse transcriptase and the bis(heteroaryl)piperazine (BHAP) U-90152 explain resistance mutations for this nonnucleoside inhibitor.
Proceedings of the National Academy of Sciences of the United States of America - 15 Apr 1997
Esnouf R M, Ren J, Hopkins A L, Ross C K, Jones E Y, Stammers D K, Stuart D I
Abstract excerpt
The viral reverse transcriptase (RT) provides an attractive target in the search for anti-HIV therapies. The nonnucleoside inhibitors (NNIs) are a diverse set of compounds (usually HIV-1 specific) that function by distorting the polymerase active site upon binding in a nearby pocket. Despite being potent and of generally low toxicity, their clinical use has been limited by rapid selection for resistant viral...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.